--- title: Recombinant Proteins, Redefined – with TargetMol description: Discover how TargetMol’s 13,000+ recombinant proteins can boost your research. Validated quality, flexible systems, and ultra-low endotoxins. image: https://blog.szabo-scandic.com/hubfs/vorlage%20blog%20TargetMol%20RECOMBINANT%20Proteins-3.jpg --- # Recombinant Proteins, Redefined – with TargetMol Written by: Melaina Mirosevic 22/04/2025 Share post on social media: [Follow us on Facebook ](whatsapp://send?text=https://blog.szabo-scandic.com/news/recombinant-proteins-redefined) [Follow us on Twitter ](https://twitter.com/intent/tweet?source=https://blog.szabo-scandic.com/news/recombinant-proteins-redefined&text=Recombinant%20Proteins,%20Redefined%20–%20with%20TargetMol%20-%20https://blog.szabo-scandic.com/news/recombinant-proteins-redefined) [Follow us on LinkedIn ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.szabo-scandic.com/news/recombinant-proteins-redefined) [Follow us on Facebook ](https://www.facebook.com/sharer/sharer.php?u=https://blog.szabo-scandic.com/news/recombinant-proteins-redefined) ![Recombinant Proteins, Redefined – with TargetMol](https://blog.szabo-scandic.com/hubfs/vorlage%20blog%20TargetMol%20RECOMBINANT%20Proteins-3.jpg) Recombinant proteins are essential tools in modern life science research. From cell culture and immunology to drug discovery and advanced therapies, they enable breakthroughs across disciplines. But not all proteins are created equal. TargetMol’s **white paper **reveals how a catalog of over **13,000 recombinant proteins** can elevate your experiments to the next level. ### Why Recombinant Proteins Matter Recombinant proteins produced via DNA/RNA technology offer significant advantages over natural sources: - High yield and reproducibility - Controlled quality and purity - Broad range of species, tags, and modifications This makes them ideal for applications such as: - Cell-based assays and culture - Protein structure and function studies - Immunology and virology research - Drug discovery and development - Cell and gene therapy ### What TargetMol Offers - **Comprehensive portfolio:** Cytokines, growth factors, CAR-T targets, checkpoint proteins, enzymes, viral proteins, and more - **Flexible expression systems:** E. coli, HEK293, insect cells, yeast, cell-free systems, and virus-like particles - **Validated quality:** Each product undergoes SDS-PAGE, HPLC, and biological activity testing. Most products have endotoxin levels below 1 EU/μg, some even under 0.01 EU/μg - **Product highlight:** Human TNF-alpha (TMPY-00936) demonstrates exceptional activity with an ED50 as low as 3–30 pg/mL in cytotoxicity assays ### Application-Specific Product Highlights **Cytokines** - EGF – Human, E. coli, tag-free - M-CSF – Mouse, HEK293, tag-free - TNF-alpha – Human, E. coli, tag-free **CAR-T Therapy Targets** - HER2 – Human, HEK293 - EGFR – Human, HEK293, His tag - BCMA – Human, HEK293, His tag **Immune Checkpoint Proteins** - PD-1 – Human, HEK293, His tag - CTLA-4 – Human, HEK293, tag-free - TIM-3 – Human, HEK293, His tag **Viral Antigens** - Hemagglutinin – Influenza A H3N2 - gp120 – HIV-1 - Fusion Glycoprotein – RSV Want to explore the full TargetMol recombinant protein catalog and find the right fit for your research? [ Download White Paper ](https://blog.szabo-scandic.com/hubfs/TargetMol%20Recombinant%20Proteins.pdf?hsLang=en)   ![Sanbio](https://144895376.fs1.hubspotusercontent-eu1.net/hubfs/144895376/images/default-author.png) #### Melaina Mirosevic [ Read more ](https://blog.szabo-scandic.com/news/author/melaina-mirosevic) ## You might also like... SEE MORE BLOGPOST ![Accelerate your Drug Discovery Research with our new Supplier BPS Bioscience](https://blog.szabo-scandic.com/hs-fs/hubfs/bps%20logo.jpg?width=600&name=bps%20logo.jpg) ##### Accelerate your Drug Discovery Research with our new Supplier BPS Bioscience 2 Min Read ![Europa Biosite Sustainability 2024: Building on Progress and Embracing the Future](https://blog.szabo-scandic.com/hs-fs/hubfs/Europa-Biosite-Sustainability-Report-2024.png?width=600&name=Europa-Biosite-Sustainability-Report-2024.png) ##### Europa Biosite Sustainability 2024: Building on Progress and Embracing the Future 2 Min Read ![Scalable RNA Extraction for High-Throughput Workflows](https://blog.szabo-scandic.com/hs-fs/hubfs/R1052_Quick-RNA-96_5760x5760.webp?width=600&name=R1052_Quick-RNA-96_5760x5760.webp) ##### Scalable RNA Extraction for High-Throughput Workflows As the RNA therapeutics and vaccine sectors continue their rapid growth, biopharma teams are in search of scalable, automation-compatible... 3 Min Read ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Melaina Mirosevic", "url" : "https://blog.szabo-scandic.com/news/author/melaina-mirosevic" }, "dateModified" : "2025-05-28T10:11:41.787Z", "datePublished" : "2025-04-22T06:30:00.000Z", "headline" : "Recombinant Proteins, Redefined – with TargetMol", "image" : [ "https://blog.szabo-scandic.com/hubfs/vorlage%20blog%20TargetMol%20RECOMBINANT%20Proteins-3.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.szabo-scandic.com/news/recombinant-proteins-redefined", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.szabo-scandic.com/hubfs/szabo/images/SzaboScandic-logo.svg" }, "name" : "SZABO-SCANDIC HandelsGmbH" } } ```